Sex Differences in Atrial Fibrillation Ablation Outcomes
from The National Inpatient Sample Database 2016-2019
Background:
Research has shown mixed results when comparing in-hospital complications following atrial
fibrillation ablation in women compared to men.
Objectives:
To better quantify sex differences and in-hospital outcomes in atrial fibrillation ablation
procedures.
Methods
We queried the National Inpatient Sample database from 2016-2019 for hospitalizations with a
primary diagnosis of atrial fibrillation ablation and excluded patients with any other arrhythmias
or ICD/pacemaker placement. We assessed demographics, in-hospital mortality, and
complications of women compared to men. Outcomes were adjusted for potential confounders
using multivariable logistic regression analysis.
Results:
Admissions for atrial fibrillation were more common in females than males (849,050 versus
815,665; p<0.001). However, females were less likely to receive ablation (1.65% versus 2.71%,
OR: 0.60; 95% confidence interval: 0.57-0.64, p<0.001) which persisted after adjusting for
cardiomyopathy (adjusted OR: 0.61; 95% confidence interval: 0.58-0.65, p<0.001). Females
undergoing catheter ablation were likely to be older (67.89 vs 63.01 years, p < 0.001), have
BMI<20 (0.49% vs. 0.0%, p<0.001), autoimmune disease (4.39% vs. 1.38%, p <0.001), COPD
(13.33% vs. 11.23%, p =0.026), valvular heart disease (2.71% vs 1.77%, p=0.03) and prior stroke
(9.48% vs. 6.60%, p<0.001) as compared to males. The primary outcome of in-hospital mortality

was not statistically different in univariate analysis (0.39% vs. 0.36%, OR: 1.09, 95% CI: 0.442.72, p=0.84), finding that did not change when adjusted for comorbidities (adjusted OR: 0.94,
95% CI: 0.36-2.49). The total unadjusted complication rate was higher for females than males
(9.58% vs. 7.09%, p=0.001); however, it was not significant when adjusted for risks (adjusted OR:
1.23, 95% CI: 0.99-1.53, p=0.06). We also found that post-procedural shock, pericardial effusion,
and overall total complications were significantly greater in females compared to the male
population undergoing cardiac ablation that resolved after adjustment for potential confounders
(Figure 1).

Conclusion:
Female sex is not associated with increased complications or death in a real-world study of catheter
ablation when results are adjusted for risks. However, females admitted with atrial fibrillation
receive ablation less often than males during hospital admission. More study is needed to identify
factors contributing to later female referral for catheter ablation.
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Figure 1: Unadjusted and adjusted odds ratios* for overall complication, inhospital mortality, pericardial effusion, pericardial drain, post-operative shock,
pseudoaneurysm, and post-procedure stroke in females compared to males.
* Adjusted for age, BMI<20, history of valvular disease, stroke, coronary artery
disease, cardiomyopathy, cancer, autoimmune disease, Elixhauser comorbidity
index and CHADS2 score.

